Phio Pharmaceuticals (PHIO) Operating Leases (2019 - 2023)
Phio Pharmaceuticals' (PHIO) quarterly Operating Leases came in at $35000.0 in Q4 2023, down 79.41% YoY from $170000.0 in Q4 2022, and down 79.41% on a QoQ basis from $170000.0 in Q4 2022.
Phio Pharmaceuticals (PHIO) Operating Leases (2019 - 2023) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 5 years of Operating Leases data on file, last reported at $35000.0 in Q4 2023.
- Quarterly Operating Leases fell 79.41% year-over-year to $35000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $35000.0 (down 79.41% YoY) and the FY2023 annual result came in at $35000.0, down 79.41% from the prior year.
- Operating Leases fell to $35000.0 in Q4 2023, from $170000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $500000.0 in Q1 2019 to a low of $35000.0 in Q4 2023.
- A 5-year average of $310705.9 and a median of $314000.0 in 2021 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2020 — Operating Leases changed 0.0% — and 2023, when it sank 79.41%.
- Tracing PHIO's Operating Leases over 5 years: stood at $411000.0 in 2019, then changed by 0.0% to $411000.0 in 2020, then fell by 28.22% to $295000.0 in 2021, then slumped by 42.37% to $170000.0 in 2022, then tumbled by 79.41% to $35000.0 in 2023.
- The last three Operating Leases figures came in at $35000.0 (Q4 2023), $170000.0 (Q4 2022), and $202000.0 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 170,000.00 |
| Sep 30, 2022 | 202,000.00 |
| Jun 30, 2022 | 104,000.00 |
| Mar 31, 2022 | 265,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 314,000.00 |
| Jun 30, 2021 | 234,000.00 |
| Mar 31, 2021 | 265,000.00 |
| Dec 31, 2020 | 411,000.00 |
| Sep 30, 2020 | 325,000.00 |
| Jun 30, 2020 | 465,000.00 |
| Mar 31, 2020 | 383,000.00 |
| Dec 31, 2019 | 411,000.00 |
| Sep 30, 2019 | 438,000.00 |
| Jun 30, 2019 | 465,000.00 |
| Mar 31, 2019 | 500,000.00 |